Insurance Stopped Covering My Weight-Loss Medication? What to Do (2026)
If your insurer stopped covering Wegovy, Zepbound, Ozempic or Mounjaro mid-treatment, do not assume the decision is final. In 2026 this is happening at scale — CVS Caremark announced it was removing Zepbound from its formulary and opened a medical-necessity exception path for people already on the drug (Massachusetts official notice), and health reporters have documented patients whose plans dropped weight-loss coverage after a year of successful treatment (KFF Health News). The fix depends on which of three things changed. This guide walks each case with the exact paperwork and deadlines.
First: read the notice and sort your case
Whether it is a denial letter, a formulary-change notice, or a pharmacy claim rejection, find the line that says why. Everything you do next depends on which of these three buckets you are in:
| Situation | What changed | Path that wins |
|---|---|---|
| 1. Formulary removal | The drug is no longer on your plan's drug list | Formulary exception (medical necessity) by your prescriber |
| 2. Renewal PA denied | A new prior-authorization was required and denied | Continuation-of-therapy appeal with clinical-improvement records |
| 3. Plan benefit change | Weight-loss drugs were excluded from the benefit itself | Usually not appealable — switch plans or escalate to HR |
Case 1 — The drug left the formulary: file a formulary exception
When a plan removes a drug from the formulary, it is a coverage decision about the list, not about your medical record. The remedy is a formulary exception request: your prescriber asks the plan to cover the drug anyway on medical-necessity grounds. In the 2026 CVS Caremark Zepbound removal, the state notice explicitly says members already taking the drug can request an exception for a case-by-case medical-necessity review (Mass.gov).
- Ask your doctor's office to submit a formulary exception request using those exact words.
- The request should say you are already stable on the drug and that switching is clinically risky — documented weight or A1c improvement plus tolerability.
- If the exception is denied, appeal it through the normal internal-appeal path (see deadlines below).
Case 2 — Renewal prior authorization denied: appeal with continuation-of-therapy evidence
Many plans require a new prior authorization every 6–12 months (Medi-Cal's GLP-1 coverage, for example, requires resubmission every 12 months (California CDPH)). A renewal denial often happens because the resubmission treated you like a brand-new patient instead of someone already responding to treatment. The winning move is a continuation-of-therapy appeal:
- Dated improvement records: weight and BMI at start vs. now, or A1c history for diabetes.
- Dose and duration: exactly which dose, for how long, without interruption.
- Tolerability: no severe side effects — you have already passed the safety hurdle.
- Comorbidity improvements: blood pressure, sleep apnea symptoms, cholesterol, or lab values that changed on the drug.
Case 3 — The plan stopped covering weight-loss drugs entirely: know when NOT to appeal
This is the honest part. If your plan or employer excluded anti-obesity medication from the benefit, a medical-necessity appeal usually loses. State regulators have upheld plan exclusions when the contract says GLP-1s for obesity are not covered — e.g., Michigan's insurance director affirmed BCBSM's denial because the member's renewed plan excluded weight-loss GLP-1s (Michigan DIFS ruling). Filing a doomed appeal only burns your deadline. Instead:
- Open enrollment: switch to a plan that covers weight-loss GLP-1s (compare formularies before you pick).
- Employer plans: ask HR whether the employer can add coverage or offer a formulary with AOM benefits — NovoCare's own guidance tells patients to take this route (NovoCare).
- Bridge options: savings-card programs, or a formulary exception for a covered indication (Wegovy's cardiovascular-risk and MASH indications, Zepbound's sleep-apnea indication) if you qualify.
Deadlines that matter
| Step | Typical window | Source of rule |
|---|---|---|
| Internal appeal (employer plans) | About 180 days from the denial notice | Federal & plan rules — check your letter |
| Medi-Cal state hearing | 90 days from the Notice of Action | California DHCS policy |
| Insurer response to pre-service appeal | 30 days (72 hours if urgent) | Federal rules |
| Peer-to-peer review request | Do it immediately — highest-yield escalation | Plan process |
Your denial or notice letter states your deadline and the exact address or portal. Mark it on a calendar; missing it closes the door.
The one-page playbook
- Read the notice and classify: formulary removal / renewal denied / benefit excluded.
- Formulary removal → prescriber files a formulary exception.
- Renewal denied → appeal with continuation-of-therapy evidence (before/after numbers).
- Benefit excluded → don't appeal the medical merits; switch plans or talk to HR.
- Either way, ask for a peer-to-peer review with the plan's medical director — it is the fastest escalation that often works.
FAQ
Why did my insurance stop covering Wegovy or Zepbound mid-treatment?
Usually one of three things: the drug was removed from your plan's formulary, your renewal prior authorization was denied, or your plan/employer changed benefits to exclude weight-loss medications. Each has a different fix.
Can I appeal if my plan removed the drug from the formulary?
Yes — ask your prescriber to file a formulary exception request. When CVS Caremark removed Zepbound from its formulary in 2026, it allowed exception requests on medical-necessity grounds for people already taking the drug.
My renewal prior authorization was denied. What documentation wins?
Continuation-of-therapy evidence: dated weight or A1c improvement on the drug, dose history, tolerability (no severe side effects), and any comorbidity improvements such as blood pressure or sleep apnea.
What if my employer plan simply stopped covering weight-loss drugs?
If the benefit itself excludes anti-obesity medication, an appeal on medical grounds rarely succeeds — state rulings have upheld plan exclusions. Your realistic options are switching plans at open enrollment, asking HR to add coverage, or exploring self-pay savings programs.
How long do I have to appeal a stopped-coverage decision?
Employer plans commonly give about 180 days for an internal appeal; Medi-Cal members have 90 days to request a state hearing. Insurers must usually respond to a pre-service appeal within 30 days (72 hours if urgent). Check your denial or notice letter for the exact deadline.